NPS Pharmaceuticals Announces New Calcilytics Agreement with GlaxoSmithKline

NPS Pharmaceuticals, Inc. NPSP today reported that it has entered into a new agreement with GlaxoSmithKline GSK, that terminates and replaces a prior collaborative research and license agreement between NPS and GSK from 1993, which focused on the discovery and development of small molecule antagonists of the calcium receptor that increase secretion of parathyroid hormone.